Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride treatment makes the prostate look more like a healthy one.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Age and other health issues affect erectile dysfunction more than finasteride or alpha-blockers.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Older patients sticking to their prostate medication saw lasting health benefits.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

Combination therapy with Finasteride is more effective than alpha-blocker alone for BPH symptoms in small prostate volume.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Taking dutasteride every other day works as well as daily and better preserves sexual function.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Finasteride helps with prostate symptoms but may cause sexual side effects.

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

Dutasteride is approved to help manage prostate enlargement.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

Man stopped medications due to sexual side effects, found relief with prostatic artery embolisation.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Dutasteride and finasteride don't raise erectile dysfunction risk.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

5-alpha-reductase inhibitors significantly affect the penile tissue of hypertensive rats.